toad.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
Mastodon server operated by David Troy, a tech pioneer and investigative journalist addressing threats to democracy. Thoughtful participation and discussion welcome.

Administered by:

Server stats:

274
active users

#studydesign

0 posts0 participants0 posts today

Versus in Treatment-Resistant (PSIKET_001) Now recruiting in

ClinicalTrials.gov ID NCT05383313
Sponsor: National Institute of Mental Health, Czech Republic clinicaltrials.gov/study/NCT05 — This study does direct comparison with an active placebo midazolam which is not an

clinicaltrials.gov/study/NCT05 Emory University plans Phase 2 study of plus a type of behavioral called Exposure Therapy for the treatment of — This study is unrelated to the MAPS/Lykos new drug application for and a reminder is robust and ongoing. should include blinding with and comparison to

finance.yahoo.com/news/atai-li Phase 1/2a Trial of ELE-101 (IV for Major Depressive Disorder, with Initial Results from Phase 1, First Patients Dosed in Phase 2a Will they blind with by iv, study with / without & compare to existing ?

Continued thread

"During these trials, the participants were randomly assigned to receive one of three commonly prescribed antidepressant medications (escitalopram, sertraline or venlafaxine extended release (XR) (n = 164)) or an established behavioral intervention that integrated problem-solving with behavioral activation, compared with treatment as usual (n = 86)” — That established behavioral intervention was using ideas that became

sciencedirect.com/science/arti Cognitive behavioral therapy following esketamine for major and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol (Kitay, et al, 2023) proposes pilot with approved formulation with

pubmed.ncbi.nlm.nih.gov/386543 Severe enduring anorexia nervosa (SE-AN) treatment options and their effectiveness: a review of literature (Marcolini, et al, 2024) on found to be valid alternative to hospitalization and more effective than “specialist supportive clinical management”